JP2015525566A5 - - Google Patents

Download PDF

Info

Publication number
JP2015525566A5
JP2015525566A5 JP2015521918A JP2015521918A JP2015525566A5 JP 2015525566 A5 JP2015525566 A5 JP 2015525566A5 JP 2015521918 A JP2015521918 A JP 2015521918A JP 2015521918 A JP2015521918 A JP 2015521918A JP 2015525566 A5 JP2015525566 A5 JP 2015525566A5
Authority
JP
Japan
Prior art keywords
composition
coli
variant
idac
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015521918A
Other languages
English (en)
Japanese (ja)
Other versions
JP6278960B2 (ja
JP2015525566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2013/000660 external-priority patent/WO2014012172A1/en
Publication of JP2015525566A publication Critical patent/JP2015525566A/ja
Publication of JP2015525566A5 publication Critical patent/JP2015525566A5/ja
Application granted granted Critical
Publication of JP6278960B2 publication Critical patent/JP6278960B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015521918A 2012-07-20 2013-07-18 非病原性f18e.coli株及びその使用 Active JP6278960B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
US61/674,179 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (3)

Publication Number Publication Date
JP2015525566A JP2015525566A (ja) 2015-09-07
JP2015525566A5 true JP2015525566A5 (enExample) 2016-09-08
JP6278960B2 JP6278960B2 (ja) 2018-02-14

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015521918A Active JP6278960B2 (ja) 2012-07-20 2013-07-18 非病原性f18e.coli株及びその使用

Country Status (17)

Country Link
US (3) US9453195B2 (enExample)
EP (1) EP2875121B1 (enExample)
JP (1) JP6278960B2 (enExample)
KR (1) KR102171028B1 (enExample)
CN (1) CN104736695B (enExample)
BR (1) BR112015001175B1 (enExample)
CA (1) CA2879155C (enExample)
DK (1) DK2875121T3 (enExample)
ES (1) ES2663019T3 (enExample)
HU (1) HUE036545T2 (enExample)
MX (1) MX363057B (enExample)
PH (1) PH12015500091B1 (enExample)
PL (1) PL2875121T3 (enExample)
PT (1) PT2875121T (enExample)
RS (1) RS57056B1 (enExample)
RU (1) RU2670882C9 (enExample)
WO (1) WO2014012172A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE036545T2 (hu) 2012-07-20 2018-07-30 Prevtec Microbia Inc Nem-patogén F18 E. coli törzs és alkalmazása
JP6731416B2 (ja) * 2015-02-11 2020-07-29 プレヴテック マイクロビア インコーポレイテッド 生きている大腸菌を埋め込むための改良された乾燥マトリクス、その製造方法及びその使用
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
RU2749883C2 (ru) * 2016-06-14 2021-06-18 Эланко Кэнэда Лимитед Гранулированный корм для животных, содержащий кормовую добавку, способ его получения и применения
WO2019006246A1 (en) * 2017-06-30 2019-01-03 The Rockefeller University N-ACYL AMIDES DERIVED FROM THE HUMAN MICROBIOTE FOR THE TREATMENT OF A HUMAN DISEASE
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
WO2000006764A1 (en) * 1998-07-30 2000-02-10 Wisconsin Alumni Research Foundation Gastrointestinal bacterial antibody factories
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
AU2002221004B2 (en) * 2000-11-30 2007-01-25 The Bio Balance Corp. Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
AU2003287028B2 (en) 2002-10-04 2008-09-04 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
WO2005074706A1 (en) * 2004-02-03 2005-08-18 Universite De Montreal Use of live bacteria for growth promotion in animals
MXPA06013253A (es) * 2004-05-14 2007-02-28 Agtech Products Inc Metodo y composicion para reducir la enfermedad de e. coli disease y mejorar el rendimiento utilizando bacilos.
US7927586B2 (en) * 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
HUE036545T2 (hu) 2012-07-20 2018-07-30 Prevtec Microbia Inc Nem-patogén F18 E. coli törzs és alkalmazása

Similar Documents

Publication Publication Date Title
JP2015525566A5 (enExample)
Villena et al. Intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection
Dubreuil Enterotoxigenic Escherichia coli and probiotics in swine: what the bleep do we know?
Pandiyan et al. Probiotics in aquaculture
Nami et al. Assessment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL
Suva et al. Novel insight on probiotic Bacillus subtilis: Mechanism of action and clinical applications
HRP20191096T1 (hr) Sastavi koje sadrže bakterijske blautia sojeve za liječenje visceralne hipersenzitivnosti
JP2018199695A5 (enExample)
HRP20191440T1 (hr) Sastavi koji sadrže bakterijske sojeve
JP2013517784A5 (enExample)
JP2019517828A5 (enExample)
JP2015213501A5 (enExample)
HRP20191738T1 (hr) Sastavi koji sadrže bakterijske sojeve
FI3074027T3 (fi) Synergistisiä bakteerikoostumuksia ja menetelmiä niiden tuottamiseksi ja käyttämiseksi
JP2015537042A5 (enExample)
RU2015105738A (ru) Непатогенный штамм f18 е. coli и его применение
JP2013522315A5 (enExample)
HRP20180152T1 (hr) Sojevi bakterija koji su izolirani iz svinja
RU2016129178A (ru) Lactobacillus salivarius для лечения мастита
RU2010142003A (ru) Синбиотическая смесь
Deng et al. Probiotics and probiotic metabolic product improved intestinal function and ameliorated LPS-induced injury in rats
NZ595914A (en) Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation
JP2019522649A5 (enExample)
Sim et al. The ameliorative role of probiotics in 5-fluorouracil induced intestinal mucositis
RU2013114313A (ru) Противокариесные композиции и пробиотики/пребиотики